Five-Years Tigecycline Experience an Analysis of Real-Life Data

Temocin, Fatih; Tulek, Necla; Hekimoglu, Sirin; Ilgar, TUBA; Bulut, Cemal; Erdinc, Fatma; Ertem, Gunay; Hatipoglu, Cigdem; Kinikli, Sami

doi:10.4274/haseki.42713

Five-Years Tigecycline Experience an Analysis of Real-Life Data

Temocin F., Tulek N. E., Hekimoglu S., Ilgar T., Bulut C., Erdinc F. S., ...Daha Fazla

HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, cilt.56, sa.2, ss.125-130, 2018 (ESCI, Scopus, TRDizin)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 56 Sayı: 2
Basım Tarihi: 2018
Doi Numarası: 10.4274/haseki.42713
Dergi Adı: HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.125-130
Anahtar Kelimeler: Tigecycline, real life data, minocycline, EFFICACY, GLYCYLCYCLINE, GAR-936, TETRACYCLINE, INFECTIONS, BINDING, SAFETY, MODEL
Recep Tayyip Erdoğan Üniversitesi Adresli: Hayır

Özet

Aim: Tigecycline has been approved by the Food and Drug Administration for the treatment of complicated intra-abdominal infections, skin and soft tissue infections and community-acquired pneumonia. In our study, we examined the efficacy of tigecycline in clinical practice and reported real life data from our hospital over a period of five years.